Ryan Wilcox

30PUBLICATIONS
124CO-AUTHORS
Molecular targetsLiquid biopsiesHaematological tumoursImmunology not elsewhere classifiedAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Aug 25, 2026
Phase 1 Trial with Soquelitinib, a Selective ITK Inhibitor for Treatment of Relapsed/Refractory T Cell Lymphomas.

|Jun 30, 2026
A single-cell atlas identifies oncogenic transcriptional programs and immune escape mechanisms in CTCL.

|Dec 02, 2025
Gene expression profiling reveals 2 overarching types of ALCL with distinct targetable biology: an LLMPP study.

Andrew L Feldman, Surendra Dasari, Lisa M Rimsza

|Nov 27, 2025
CDK9 is a dependency in GATA-3 driven and MCL-1 independent T-cell Lymphomas.

Chenguang Wang, Suhaib Abdelrahman, Xiangrong Geng

|Sep 27, 2025
Transcriptional Analysis of Effusion-Based Lymphoma Supports a Post-Germinal Center Origin and Specific Inflammatory Signal Background.

Vanessa Perez-Silos, Hojung Kim, Chenguang Wang

|Jun 11, 2025
Mycosis Fungoides, Sézary Syndrome, and Cutaneous B-Cell Lymphomas: 2025 Update on Diagnosis, Risk-Stratification, and Management.

Alexandra C Hristov, Trilokraj Tejasvi, Ryan A Wilcox

Pageof 5

Frequent Collaborators

9 joint publications

Carlos Murga-Zamalloa

8 joint publications

Chenguang Wang

5 joint publications

Ashley Wolfe

4 joint publications

John Reneau